• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Sutter Health Taps Qventus’ AI Platform to Manage Drug Costs Across 30 Pharmacies

by Jasmine Pennic 09/05/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Sutter Health Taps Qventus’ AI Platform to Manage Drug Costs Across 30 Pharmacies

Sutter Health, one of the top five large-health systems in the US, announced they are using Qventus’ artificial intelligence platform in 30 pharmacies across their system. Initially, the platform will launch at four strategically chosen hospital sites within the health system’s network, then quickly roll out to 26 additional sites.

With inpatient drug costs at an all-time high, Sutter will work with Qventus to better manage drug costs and help determine where a pharmacist-led intervention may be needed to ensure that patients receive the most appropriate medications for their treatment. The Qventusplatform will also help pharmacists prioritize the neediest patients for drug consultation, which can help increase adherence, reduce errors and improve compliance.  

To do so, Qventus software uses NLP/ML to mine hospital, patient and pharmacy data in real-time to identify opportunities to reduce drug spending and mitigate other issues. For example, reducing readmissions by identifying patients who would benefit from additional pharmacist counseling or medication education due to the complex nature of their medication regimens or discharge instructions.

Pharmacy operations is a growing opportunity for hospitals. More than 90 percent of hospital leaders report that price hikes for inpatient drugs have had a moderate or severe effect on managing overall costs. Additionally, hospital pharmacists understand the need to balance personalized service with increasing patient volumes. Clinicians have the added challenge of managing and monitoring lots of pharmaceutical usage data across disparate systems.

“Applying Qventus’ artificial intelligence to our pharmaceutical operations allows us to identify areas of improvement while keeping the focus on those in our care,” said Ryan Stice, PharmD, executive director of Pharmacy at Sutter Health. “This platform can help our care teams have more meaningful conversations with our patients—helping explain care plans in ways they understand and ensure they feel supported.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Sutter Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |